128 related articles for article (PubMed ID: 8811128)
1. Amplification of the cyclin-dependent kinase 4 (CDK4) gene is associated with high cdk4 protein levels in glioblastoma multiforme.
Rollbrocker B; Waha A; Louis DN; Wiestler OD; von Deimling A
Acta Neuropathol; 1996 Jul; 92(1):70-4. PubMed ID: 8811128
[TBL] [Abstract][Full Text] [Related]
2. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.
Reifenberger G; Ichimura K; Reifenberger J; Elkahloun AG; Meltzer PS; Collins VP
Cancer Res; 1996 Nov; 56(22):5141-5. PubMed ID: 8912848
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas.
Burns KL; Ueki K; Jhung SL; Koh J; Louis DN
J Neuropathol Exp Neurol; 1998 Feb; 57(2):122-30. PubMed ID: 9600204
[TBL] [Abstract][Full Text] [Related]
4. Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas.
Büschges R; Weber RG; Actor B; Lichter P; Collins VP; Reifenberger G
Brain Pathol; 1999 Jul; 9(3):435-42; discussion 432-3. PubMed ID: 10416984
[TBL] [Abstract][Full Text] [Related]
5. Differential polymerase chain reaction: a technical comparison of three methods for the detection of CDK4 gene amplification in glioblastomas.
Fan X; Gómez L; Nistal M; Sierrasesúmaga L; Castresana JS
Int J Oncol; 1998 Nov; 13(5):963-6. PubMed ID: 9772286
[TBL] [Abstract][Full Text] [Related]
6. Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation.
An HX; Beckmann MW; Reifenberger G; Bender HG; Niederacher D
Am J Pathol; 1999 Jan; 154(1):113-8. PubMed ID: 9916925
[TBL] [Abstract][Full Text] [Related]
7. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
Sonoda Y; Yoshimoto T; Sekiya T
Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535
[TBL] [Abstract][Full Text] [Related]
8. Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene.
Ichimura K; Schmidt EE; Goike HM; Collins VP
Oncogene; 1996 Sep; 13(5):1065-72. PubMed ID: 8806696
[TBL] [Abstract][Full Text] [Related]
9. CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons.
Wei G; Lonardo F; Ueda T; Kim T; Huvos AG; Healey JH; Ladanyi M
Int J Cancer; 1999 Jan; 80(2):199-204. PubMed ID: 9935200
[TBL] [Abstract][Full Text] [Related]
10. Comparative molecular genetic profiles of anaplastic astrocytomas/glioblastomas multiforme and their subsequent recurrences.
Saxena A; Shriml LM; Dean M; Ali IU
Oncogene; 1999 Feb; 18(6):1385-90. PubMed ID: 10022821
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic changes in a series of neuroepithelial tumors of childhood.
Di Sapio A; Morra I; Pradotto L; Guido M; Schiffer D; Mauro A
J Neurooncol; 2002 Sep; 59(2):117-22. PubMed ID: 12241104
[TBL] [Abstract][Full Text] [Related]
12. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2.
Reifenberger G; Reifenberger J; Ichimura K; Meltzer PS; Collins VP
Cancer Res; 1994 Aug; 54(16):4299-303. PubMed ID: 8044775
[TBL] [Abstract][Full Text] [Related]
13. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities of p16, p15 and CDK4 genes in recurrent malignant astrocytomas.
Saxena A; Robertson JT; Ali IU
Oncogene; 1996 Aug; 13(3):661-4. PubMed ID: 8760309
[TBL] [Abstract][Full Text] [Related]
15. Glioblastoma-related gene mutations and over-expression of functional epidermal growth factor receptors in SKMG-3 glioma cells.
Thomas C; Ely G; James CD; Jenkins R; Kastan M; Jedlicka A; Burger P; Wharen R
Acta Neuropathol; 2001 Jun; 101(6):605-15. PubMed ID: 11515790
[TBL] [Abstract][Full Text] [Related]
16. CDK4 is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer.
Wikman H; Nymark P; Väyrynen A; Jarmalaite S; Kallioniemi A; Salmenkivi K; Vainio-Siukola K; Husgafvel-Pursiainen K; Knuutila S; Wolf M; Anttila S
Genes Chromosomes Cancer; 2005 Feb; 42(2):193-9. PubMed ID: 15543620
[TBL] [Abstract][Full Text] [Related]
17. Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas.
Biernat W; Tohma Y; Yonekawa Y; Kleihues P; Ohgaki H
Acta Neuropathol; 1997 Oct; 94(4):303-9. PubMed ID: 9341929
[TBL] [Abstract][Full Text] [Related]
18. Mutations of TP53, amplification of EGFR, MDM2 and CDK4, and deletions of CDKN2A in malignant astrocytomas.
Biernat W; Debiec-Rychter M; Liberski PP
Pol J Pathol; 1998; 49(4):267-71. PubMed ID: 10323080
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.
Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R
Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847
[TBL] [Abstract][Full Text] [Related]
20. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma.
Gao L; Liu L; van Meyel D; Cairncross G; Forsyth P; Kimmel D; Jenkins RB; Lassam NJ; Hogg D
Clin Cancer Res; 1997 Jun; 3(6):977-81. PubMed ID: 9815774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
